Akebia Therapeutics (AKBA) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.1
-0.08
-0.06
-0.04

Details

Expected EPS
-0.080733
Actual EPS
-0.1
Surprise EPS
-0.02
Surprise Percent
+23.87%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.1 per share for Q1 2025.

0 Comments

Share your thoughts